TuisNTRA • NASDAQ
add
Natera Inc
Vorige sluiting
$122,35
Dagwisseling
$121,64 - $124,47
Jaarwisseling
$36,90 - $133,54
Markkapitalisasie
15,14 mjd USD
Gemiddelde volume
1,11 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 413,35 m | 58,13% |
Bedryfskoste | 287,07 m | 24,45% |
Netto inkomste | -37,46 m | 66,19% |
Netto winsgrens | -9,06 | 78,63% |
Wins per aandeel | -0,30 | 69,07% |
EBITDA | -35,99 m | 66,46% |
Effektiewe belastingkoers | -2,44% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 887,10 m | 20,54% |
Totale bates | 1,52 mjd | 21,56% |
Totale aanspreeklikheid | 680,47 m | 4,41% |
Totale ekwiteit | 836,52 m | — |
Uitstaande aandele | 123,68 m | — |
Prys om te bespreek | 18,05 | — |
Opbrengs op bates | -7,35% | — |
Opbrengs op kapitaal | -8,75% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -37,46 m | 66,19% |
Kontant van bedrywe | 3,99 m | 105,08% |
Kontant van beleggings | -32,05 m | -167,92% |
Kontant van finansiering | 11,04 m | 18,60% |
Netto kontantverandering | -17,02 m | 22,78% |
Beskikbare kontantvloei | 6,78 m | 111,62% |
Meer oor
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Gestig
01 Jan. 2004
Hoofkwartier
Webwerf
Werknemers
3 288
